SEC 13F Intelligence

Bios Capital Management, LP / IRD

Bios Capital Management, LP’s Opus Genetics Inc Position

Does Bios Capital Management, LP own Opus Genetics Inc (IRD)? Yes — 3.68M shares worth $17M (+31.70% of its 13F portfolio) as of Q1 2026.

Position Value
$17M
Q1 2026
Shares
3.68M
% of Portfolio
+31.70%
Quarters Held
6
currently held

Position History IRD

Reported value by quarter
Q4 ’24: $1MQ4 ’24Q1 ’25: $977,135Q1 ’25Q2 ’25: $3MQ2 ’25Q3 ’25: $7MQ3 ’25Q4 ’25: $7MQ4 ’25Q1 ’26: $17MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.68M$17M+31.70%
Q4 20253.68M$7M+8.96%
Q3 20253.68M$7M+7.42%
Q2 20253.68M$3M+4.77%
Q1 2025995.2K$977,135+1.23%
Q4 2024995.2K$1M+1.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bios Capital Management, LP’s full portfolio or all institutional holders of IRD.